6 Stocks Positioned to Soar as Investors Focus on MASHInvestors are making a lot of money on obesity plays. Obesity is at epidemic proportions, so it's easy to see why obesity drugs including GLP-1 agonists have exploded in the marketplace. This class of drugs was originally designed to manage blood sugar levels in diabetics but was expanded to treat obesity, an even bigger market. JP Morgan analyst Richard Vosser estimated the global obesity drug market will reach $71 billion by 2032.
7 Stocks That Will Drive the Weight Loss Drugs MarketThe booming weight loss drug market presents both lucrative potential and significant risks for investors seeking to capitalize on the global obesity crisis.
Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) is a Leading Gainer in 3/15 Morning TradingMadrigal Pharmaceuticals, Inc. (
NASDAQMDGL) is one of today’s top gainers. The company’s shares have moved 18.78% on the day to $289.32.
Analysts see over 50% gains in these 2 mid-cap biotech stocksThe outlook for growth has made biotech one of the hottest investments of late - and Wall Street sees big comeback gains ahead in these two biotechs.
Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) is a Leading Gainer in 9/13 Morning TradingMadrigal Pharmaceuticals, Inc. (
NASDAQMDGL) is one of today’s top gainers. The company’s shares are currently up 6.53% on the day to $188.42.
Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) is a Leading Gainer in 3/17 Morning TradingMadrigal Pharmaceuticals, Inc. (
NASDAQMDGL) is one of today’s top gainers. The company’s shares are currently up 1.46% on the day to $249.48.
Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) Making Surprising Moves in Tuesday SessionMadrigal Pharmaceuticals, Inc. (
NASDAQMDGL) has caught the attention of the investment community today with its bullish price action. The company’s shares are currently up 2.6% on the day to $292.92.
Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) Making Surprising Moves in Tuesday SessionMadrigal Pharmaceuticals, Inc. (
NASDAQMDGL) has caught the attention of the investment community today with its bullish price action. The company’s shares are currently up 10.76% on the day to $284.15.
Want Diversified Upside in Biotechnology? Check out LABUWatch the Direxion Daily S&P 500 Biotech Bull 3X Shares (
NYSELABU) if you want a speculative play in the biotechnology industry with amplified volatility.
Why Did Viking Therapeutics Stock SkyrocketVKTX stock is young but strong and they have excellent potential, particularly following successful trial results from Madrigal Pharma's recent drug trial.
Madrigal Pharmaceuticals Stock Is Up 200% In One Day, Here's WhyMadrigal Pharmaceuticals announced positive results for a major clinical trial and shares are up more than 200% because of it.
